Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
about
Challenging tumour immunological techniques that help to track cancer stem cells in malignant melanomas and other solid tumours.The Critical, Clinical Role of Interferon-Beta in Regulating Cancer Stem Cell Properties in Triple-Negative Breast Cancer.Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance
P2860
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
@en
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
@nl
type
label
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
@en
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
@nl
prefLabel
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
@en
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
@nl
P2093
P2860
P356
P1476
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
@en
P2093
Damian J Junk
George R Stark
HyeonJoo Cheon
Mark W Jackson
Mary R Doherty
Melinda L Telli
Shaveta Vinayak
Vinay Varadan
P2860
P304
13792-13797
P356
10.1073/PNAS.1713728114
P407
P50
P577
2017-12-11T00:00:00Z